LoginRegister
    Cipla appoints Dr Raju Mistry as Global Chief People OfficerCipla appoints Dr Raju Mistry as Global Chief People Officer
    Medicare hospital fund reserves likely to be exhausted in 2026: US reportMedicare hospital fund reserves likely to be exhausted in 2026: US report
    Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tabletsPatent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin...
    Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solutionAlembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution
    Torrent Pharma recalls over 10.78 lakh bottles of Losartan citing CGMP deviationsTorrent Pharma recalls over 10.78 lakh bottles of Losartan citing CGMP deviations
    Merck wins USFDA approval for Keytruda as combo therapy for kidney cancerMerck wins USFDA approval for Keytruda as combo therapy for kidney cancer
    Measles Outbreak: Judge refuses to lift NYCs mandatory vaccination orderMeasles Outbreak: Judge refuses to lift NYCs mandatory vaccination order
    Novotech partners with major hospitals to strengthen South Korean clinical capabilitiesNovotech partners with major hospitals to strengthen South Korean clinical capabilities
    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysisDrugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination,...
    Merck Foundation defines interventions to break infertility stigma at IFFS World CongressMerck Foundation defines interventions to break infertility stigma at IFFS World Congress
    USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdoseUSFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose
    AMO Pharma launches clinician-completed rating scale for congenital myotonic dystrophy type 1AMO Pharma launches clinician-completed rating scale for congenital myotonic dystrophy type 1
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X